report the first-year outcomes of a 2-year, multicenter, parallel group, randomized, controlled trial to evaluate the efficacy and safety of twice-monthly versus daily oral risedronate for ...
Glucocorticosteroids, when administered in greater doses than physiological concentrations ... alendronate and risedronate, while zoledronate or teriparatide should be considered as the second ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback